Stay updated on Granix Disruption in Myeloma Transplant Clinical Trial
Sign up to get notified when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.

Latest updates to the Granix Disruption in Myeloma Transplant Clinical Trial page
- Check3 days agoChange DetectedThe page shows an updated revision label (v3.3.4) replacing the previous (v3.3.3), with no changes to study details or eligibility criteria.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations were added to the page, including Missouri, indicating where the study is conducted. A related location entry and certain footer items were removed.SummaryDifference0.4%

- Check46 days agoChange DetectedThe page removes the 'Multiple Myeloma' entry and the related topics section 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded a related topic link to MedlinePlus Genetics and updated the page revision to v3.3.2.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page no longer displays the government funding notice and related topics (Multiple Myeloma and MedlinePlus Genetics). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check74 days agoChange DetectedAdded mentions of multiple myeloma as the disease context and expanded sponsor/affiliation details (Washington University School of Medicine and Alvin J. Siteman Cancer Center), along with related topic links such as MedlinePlus Genetics.SummaryDifference0.8%

Stay in the know with updates to Granix Disruption in Myeloma Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.